SynthesisJournal of neurology, neurosurgery, and psychiatry2025

Comorbidities, safety and persistence in phase III clinical trials in multiple sclerosis.

Amber Salter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.